Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Dec;26(Suppl 3):715-716.
doi: 10.1245/s10434-019-07769-y. Epub 2019 Aug 29.

ASO Author Reflections: Early-Stage Lobular Breast Cancer: Axillary Treatment in the Z0011 Era

Anita Mamtani  1 , Monica Morrow  2
Affiliations
Comment

ASO Author Reflections: Early-Stage Lobular Breast Cancer: Axillary Treatment in the Z0011 Era

Anita Mamtani et al. Ann Surg Oncol. 2019 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Rakha EA, Ellis IO. Lobular breast carcinoma and its variants. Semin Diagn Pathol. February 2010;27(1):49–61. - PubMed
    1. Giuliano AE, Ballman K, McCall L, et al. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. Sep 2016;264(3):413–420. - PMC - PubMed
    1. Caudle AS, Hunt KK, Tucker SL, et al. American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann Surg Oncol. October 2012;19(10):3144–3151. - PMC - PubMed
    1. Mamtani A, Zabor EC, Stempel M, et al. Lobular histology does not predict the need for axillary dissection among ACOSOG Z0011-eligible breast cancers. Ann Surg Oncol. 2019. 10.1245/s10434-019-07536-z - DOI - PMC - PubMed
    1. Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. Aug 27 2011;378(9793):771–784. - PMC - PubMed